Shaun Hager, DO
Urology · Norwich, CTNPI 1740638352
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $18,800 of the $20,512 with a category attached, or 91.7%. Medtronic accounts for 92.2% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $18,874, more than ten times the $925 reported in 2019. Among urology clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 37 payments — averaging $554.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$19K
- Boston Scientific$683
- Coloplast$158
- Dendreon Pharmaceuticals LLC$149
- Blue Earth Diagnostics$146
- C. R. Bard, Inc. & Subsidiaries$127
- plus $331 from 8 others
What the payments were for
- Consulting fees$18,80092%
- Food & beverage$1,7128%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 8 | $18,917 |
| Boston Scientific | 12 | $683 |
| Coloplast | 2 | $158 |
| Dendreon Pharmaceuticals LLC | 1 | $149 |
| Blue Earth Diagnostics | 2 | $146 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $127 |
| Myovant Sciences Inc. | 1 | $109 |
| Janssen Scientific Affairs, LLC | 1 | $92 |
| Procept Biorobotics Corporation | 1 | $33 |
| Astellas Pharma US Inc | 2 | $30 |
| Axonics, Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Foundation Medicine, Inc. | 1 | $13 |
| Telix Pharmaceuticals | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,512 in reported general payments places this provider in the 90th percentile of 156 urology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 109 | $70,828 |
| GemtesaVibegron | 24 | $18,999 |
| Mirabegron ErMirabegron | 24 | $15,974 |
| Tamsulosin Hcl | 310 | $3,655 |
| Potassium Citrate ErPotassium Citrate | 12 | $1,316 |
| Estradiol | 23 | $1,207 |
| Tadalafil | 13 | $1,205 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 70 | $1,152 |
| Finasteride | 108 | $949 |
| Methenamine Hippurate | 12 | $731 |
| Oxybutynin Chloride ErOxybutynin Chloride | 32 | $689 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 20 | $597 |
| Testosterone Cypionate | 20 | $197 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 11 | $185 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 55 | $181 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $30 | $70,828109 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 156 urology providers in Connecticut.
Other urology in Norwich
- Daniel KellnerNew Haven$122K
- Gerard PregenzerEnfield$92K
- Mary SoysterTorrington$58K
- Preston SprenkleNew Haven$57K
- Grace BiggsDerby$52K
- Stanton HonigNew Haven$40K
- Joshua SteinNew Britain$30K
- Steven ShichmanHartford$28K
- Christine LiawBridgeport$27K
- David CrawleyNew London$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.